OCT Image Quality Performance Evaluation

Healthy Eyes Clinical Trial

Official title:

OCT Image Quality Performance Evaluation

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02991027
• Other study ID #: Topcon Tabil-801-2016
• Status: Withdrawn
• Phase: N/A
• Start date: December 14, 2016
• Est. completion date: July 2, 2017

Study information

• Verified date: October 2021
• Source: Topcon Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the image qualities and segmentation performance of Topcon's DRI OCT Triton devices using two light sources.

Description:

To evaluate the image qualities and segmentation performance of Topcon's DRI OCT Triton devices using two light sources with equivalent specifications: the micro-electro-mechanical short cavity tunable laser and the micro-electro-mechanical tunable vertical cavity surface emitting laser.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 2, 2017
• Est. primary completion date: June 12, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria

1. Participants must be at least 18 years of age

2. They must be able to complete all testing (all OCT scans)

3. They must volunteer to be in the study and sign the consent form

Exclusion Criteria

1. Subject with history of ocular disease or ocular pathology

2. Subjects unable to complete all OCT imaging modes

Related Conditions & MeSH terms

• Healthy Eyes

Intervention

Device:
• DRI OCT Triton
DRI OCT Triton using micro-electro-mechanical short cavity tunable laser
• DRI OCT Triton
DRI OCT Triton using micro-electro-mechanical tunable vertical cavity surface emitting laser

Locations

Country	Name	City	State
United States	Topcon Medical Systems Inc.	Oakland	New Jersey

Sponsors (1)

Lead Sponsor	Collaborator
Topcon Medical Systems, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	OCT image quality		5 minutes
Primary	OCT angiography image quality		5 minutes
Secondary	Full Retinal Thickness		5 minutes